ARCHIVE

• Fuso: Stiffer Competition Squeezes Profits
  June 17, 2002

• REGULATORY NEWS IN BRIEF
  June 17, 2002

• Sanofi-Synthelabo Reports Hypotensive Effects of Irbesartan
  June 17, 2002

• Nippon Chemiphar: New Gout Treatment GL to Remarkably Boost Sales, Profits
  June 17, 2002

• If Generics Were 60% Cheaper, 22% of Patients Would Choose Them: Survey
  June 17, 2002

• Enrollment Completed for Major Int'l Stroke Prevention Trial: Sanofi-Sythelabo
  June 17, 2002

• Kaken: Sales Up 4.2%, Effects of Competitors on Artz Are Minimal
  June 10, 2002

• Taisho Licenses mGluR Agonists to Merck
  June 10, 2002

• MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
  June 10, 2002

• SSP: Sales, Profits Plummet Due to Slump in Self-medication
  June 10, 2002

• Chugai, Biostar, Jicchuken Create Post-genomic Research Company in Singapore
  June 10, 2002

• Late PII Results on Humanized Antibody MRA Reported: Chugai
  June 10, 2002

• Mochida: Sales Down Due to Decline in Mainstays
  June 10, 2002

• Sosei Introduces Brain Tumor Treatment from KS Biomedix of the UK
  June 10, 2002

• Fulminant Type 1 Diabetes Can Be Fatal if not Treated Immediately
  June 10, 2002

• Kyorin: New Record-high Consolidated Sales Reported
  June 10, 2002

• Santen Signs Agreement with Koken for Dry Eye Products
  June 10, 2002

• MEDICAL DEVICE NEWS IN BRIEF
  June 10, 2002

• Kissei: Princeton Bonds Compromise Brings Profits Up
  June 10, 2002

• CMIC to Be Listed on JASDAQ
  June 10, 2002

ページ

• « 先頭
• ‹ Prev
• …
• 673
• 674
• 675
• 676
• 677
• 678
• 679
• 680
• 681
• …
• Next ›
• 最終 »